A DOUBLE blind control study of antihypertensive agents. I. Comparative effectiveness of reserpine, reserpine and hydralazine, and three ganglionic blocking agents, chlorisondamine, mecamyamine, and pentolinium tartrate - PubMed (original) (raw)

• PMID: 13856546

A DOUBLE blind control study of antihypertensive agents. I. Comparative effectiveness of reserpine, reserpine and hydralazine, and three ganglionic blocking agents, chlorisondamine, mecamyamine, and pentolinium tartrate

No authors listed. Arch Intern Med. 1960 Jul.

No abstract available

PubMed Disclaimer

Similar articles

• Drug therapy of hypertension. II. Experience with reserpine, apresoline, ansolysen, ecolid, and mecamylamine (inversine).
  MOSER M, MACAULAY AI, GRANZEN R, TROUT KW. MOSER M, et al. N Y State J Med. 1956 Aug 15;56(16):2487-97. N Y State J Med. 1956. PMID: 13348892 No abstract available.
• CHEMOTHERAPY OF HYPERTENSION: YESTERDAY--TODAY--TOMORROW.
  SJOERDSMA A. SJOERDSMA A. Circulation. 1963 Aug;28:161-4. doi: 10.1161/01.cir.28.2.161. Circulation. 1963. PMID: 14051535 No abstract available.
• EFFECT OF GANGLION BLOCKING DRUGS ON THE RESPONSES OF THE RABBIT AORTIC STRIP TO ADRENALINE, NORADRENALINE AND OTHER VASOACTIVE SUBSTANCES.
  KELKAR VV, GULATI OD, GOKHALE SD. KELKAR VV, et al. Arch Int Pharmacodyn Ther. 1964 May 1;149:209-22. Arch Int Pharmacodyn Ther. 1964. PMID: 14169884 No abstract available.
• [MALIGNANT HYPERTENSION].
  CHIRONE E. CHIRONE E. Policlinico Prat. 1964 Mar 2;71:325-38. Policlinico Prat. 1964. PMID: 14143292 Review. Italian. No abstract available.
• Uropharmacology: VII. Ganglionic stimulating and blocking agents.
  Bissada NK, Welch LT, Finkbeiner AE. Bissada NK, et al. Urology. 1978 Apr;11(4):425-31. doi: 10.1016/0090-4295(78)90252-2. Urology. 1978. PMID: 27000 Review.

Cited by

• Impact of Department of Veterans Affairs Cooperative Studies Program clinical trials on practice guidelines for high blood pressure management.
  Henrie AM, Sather MR, Bakhireva LN, Nawarskas JJ, Boardman KD, Huang GD. Henrie AM, et al. Contemp Clin Trials Commun. 2018 Dec 4;13:100313. doi: 10.1016/j.conctc.2018.100313. eCollection 2019 Mar. Contemp Clin Trials Commun. 2018. PMID: 30582070 Free PMC article.
• Pharmacotherapy for hypertension in adults aged 18 to 59 years.
  Musini VM, Gueyffier F, Puil L, Salzwedel DM, Wright JM. Musini VM, et al. Cochrane Database Syst Rev. 2017 Aug 16;8(8):CD008276. doi: 10.1002/14651858.CD008276.pub2. Cochrane Database Syst Rev. 2017. PMID: 28813123 Free PMC article. Review.
• [Aldosterone excretion in patients with essential hypertension after variable sodium loading (author's transl)].
  Helber A, Meurer KA, Wambach G, Kaufmann W. Helber A, et al. Klin Wochenschr. 1974 Jan 15;52(2):90-6. doi: 10.1007/BF01468331. Klin Wochenschr. 1974. PMID: 4816959 German. No abstract available.
• Pharmacotherapy for hypertension in adults 60 years or older.
  Musini VM, Tejani AM, Bassett K, Puil L, Wright JM. Musini VM, et al. Cochrane Database Syst Rev. 2019 Jun 5;6(6):CD000028. doi: 10.1002/14651858.CD000028.pub3. Cochrane Database Syst Rev. 2019. PMID: 31167038 Free PMC article.
• Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals.
  Taverny G, Mimouni Y, LeDigarcher A, Chevalier P, Thijs L, Wright JM, Gueyffier F. Taverny G, et al. Cochrane Database Syst Rev. 2016 Mar 10;3(3):CD011745. doi: 10.1002/14651858.CD011745.pub2. Cochrane Database Syst Rev. 2016. PMID: 26961575 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems